Cassava Sciences to discontinue all efforts to develop simufilam in Alzheimer’s
We are disappointed that the results of REFOCUS-ALZ and RETHINK-ALZ showed no treatment benefit for patients with mild-to-moderate Alzheimer’s ...
Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data
Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with ...
inkbotdesign.com24d
The Apple Logo History, Meaning and Evolution
From its origins in a garage to becoming one of the most recognisable symbols in the world, explore the story behind the iconic Apple logo design. Apple is a company that has changed the technology ...
Metro26d
Barclays announces £12,500,000 outage payout for millions of customers — are you eligible?
According to the Treasury Select Committee (TSC) of MPs, Barclays is expected to pay out between £5 million and £7.5 million for the ‘inconvenience or distress’ of the outages earlier this ...